Matches in SemOpenAlex for { <https://semopenalex.org/work/W3163959225> ?p ?o ?g. }
- W3163959225 endingPage "176" @default.
- W3163959225 startingPage "165" @default.
- W3163959225 abstract "No studies evaluating the rapidity of response to biological therapies are available for Crohn's disease (CD). The aim of this study was to evaluate rapidity of onset of clinical response and impact on quality of life (QoL) of adalimumab therapy in adult anti-TNF-naïve patients with moderately-to-severely active CD.RAPIDA was an open-label, single-arm, prospective, multicenter clinical trial. Adult patients with moderately-to-severely active luminal CD, anti-TNF-naïve, and unresponsive to conventional therapy were treated with adalimumab. Clinical disease activity, QoL and inflammatory biomarkers were measured at day 4, and weeks 1, 2, 4, and 12 after treatment initiation.Eighty-six patients were included in the intention-to-treat (ITT) analyses. Clinical disease activity was reduced from a median of 9.0 points to 6.0 points at day 4. Clinical response (≥ 3-point reduction in the Harvey-Bradshaw Index, HBI) was achieved by 61.6% (d4) and 75.6% (w1) of patients in the ITT population (median 2.5 days) and with non-responder imputation (NRI), by 55.8% and 53.4%, respectively. The proportion of patients in clinical remission (HBI<5) at weeks 2 and 4 in the ITT population was 54.7% and 62.8%, respectively (median 7.0 days), and 38.4% and 45.3% in the NRI population. All QoL scores significantly improved and inflammatory biomarkers significantly decreased from day 4 onwards (p<0.0001).Rapid clinical response and remission, improvement in QoL and fatigue, and a reduction of inflammatory biomarkers were achieved with adalimumab as early as day 4 in adult anti-TNF-naïve patients with moderately-to-severely active CD." @default.
- W3163959225 created "2021-06-07" @default.
- W3163959225 creator A5007019089 @default.
- W3163959225 creator A5009378311 @default.
- W3163959225 creator A5011593256 @default.
- W3163959225 creator A5023730578 @default.
- W3163959225 creator A5024000789 @default.
- W3163959225 creator A5028145761 @default.
- W3163959225 creator A5031317742 @default.
- W3163959225 creator A5033282443 @default.
- W3163959225 creator A5040944358 @default.
- W3163959225 creator A5043396998 @default.
- W3163959225 creator A5046714802 @default.
- W3163959225 creator A5046814332 @default.
- W3163959225 creator A5049138418 @default.
- W3163959225 creator A5051728887 @default.
- W3163959225 creator A5052947148 @default.
- W3163959225 creator A5053104917 @default.
- W3163959225 creator A5056652716 @default.
- W3163959225 creator A5091186900 @default.
- W3163959225 date "2022-03-01" @default.
- W3163959225 modified "2023-10-17" @default.
- W3163959225 title "Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study" @default.
- W3163959225 cites W1562131205 @default.
- W3163959225 cites W1886704136 @default.
- W3163959225 cites W1968616184 @default.
- W3163959225 cites W1985746774 @default.
- W3163959225 cites W1991810959 @default.
- W3163959225 cites W2006360844 @default.
- W3163959225 cites W2008497900 @default.
- W3163959225 cites W2022661087 @default.
- W3163959225 cites W2024959214 @default.
- W3163959225 cites W2041428141 @default.
- W3163959225 cites W2055211617 @default.
- W3163959225 cites W2065235857 @default.
- W3163959225 cites W2089176308 @default.
- W3163959225 cites W2111570058 @default.
- W3163959225 cites W2125626931 @default.
- W3163959225 cites W2125799301 @default.
- W3163959225 cites W2129558176 @default.
- W3163959225 cites W2149170290 @default.
- W3163959225 cites W2152026434 @default.
- W3163959225 cites W2163123800 @default.
- W3163959225 cites W2170393161 @default.
- W3163959225 cites W2171341132 @default.
- W3163959225 cites W2521454913 @default.
- W3163959225 cites W2523706394 @default.
- W3163959225 cites W2563342462 @default.
- W3163959225 cites W2757742334 @default.
- W3163959225 cites W4231630787 @default.
- W3163959225 cites W4237097915 @default.
- W3163959225 doi "https://doi.org/10.1016/j.gastrohep.2021.04.010" @default.
- W3163959225 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34051313" @default.
- W3163959225 hasPublicationYear "2022" @default.
- W3163959225 type Work @default.
- W3163959225 sameAs 3163959225 @default.
- W3163959225 citedByCount "3" @default.
- W3163959225 countsByYear W31639592252022 @default.
- W3163959225 countsByYear W31639592252023 @default.
- W3163959225 crossrefType "journal-article" @default.
- W3163959225 hasAuthorship W3163959225A5007019089 @default.
- W3163959225 hasAuthorship W3163959225A5009378311 @default.
- W3163959225 hasAuthorship W3163959225A5011593256 @default.
- W3163959225 hasAuthorship W3163959225A5023730578 @default.
- W3163959225 hasAuthorship W3163959225A5024000789 @default.
- W3163959225 hasAuthorship W3163959225A5028145761 @default.
- W3163959225 hasAuthorship W3163959225A5031317742 @default.
- W3163959225 hasAuthorship W3163959225A5033282443 @default.
- W3163959225 hasAuthorship W3163959225A5040944358 @default.
- W3163959225 hasAuthorship W3163959225A5043396998 @default.
- W3163959225 hasAuthorship W3163959225A5046714802 @default.
- W3163959225 hasAuthorship W3163959225A5046814332 @default.
- W3163959225 hasAuthorship W3163959225A5049138418 @default.
- W3163959225 hasAuthorship W3163959225A5051728887 @default.
- W3163959225 hasAuthorship W3163959225A5052947148 @default.
- W3163959225 hasAuthorship W3163959225A5053104917 @default.
- W3163959225 hasAuthorship W3163959225A5056652716 @default.
- W3163959225 hasAuthorship W3163959225A5091186900 @default.
- W3163959225 hasConcept C126322002 @default.
- W3163959225 hasConcept C141071460 @default.
- W3163959225 hasConcept C159110408 @default.
- W3163959225 hasConcept C1862650 @default.
- W3163959225 hasConcept C188816634 @default.
- W3163959225 hasConcept C2779134260 @default.
- W3163959225 hasConcept C2779280984 @default.
- W3163959225 hasConcept C2779951463 @default.
- W3163959225 hasConcept C2780132546 @default.
- W3163959225 hasConcept C2908647359 @default.
- W3163959225 hasConcept C535046627 @default.
- W3163959225 hasConcept C71924100 @default.
- W3163959225 hasConcept C90924648 @default.
- W3163959225 hasConcept C99454951 @default.
- W3163959225 hasConceptScore W3163959225C126322002 @default.
- W3163959225 hasConceptScore W3163959225C141071460 @default.
- W3163959225 hasConceptScore W3163959225C159110408 @default.
- W3163959225 hasConceptScore W3163959225C1862650 @default.
- W3163959225 hasConceptScore W3163959225C188816634 @default.
- W3163959225 hasConceptScore W3163959225C2779134260 @default.